Comprehensive approach to the treatment of patients with coronary artery disease within medicine framework

The article is devoted to an integrated approach to the treatment of patients with coronary heart disease (CHD) in clinical practice. Modern methods of diagnosis and treatment aimed at improving the quality of life and prognosis of patients with this disease are considered. The article emphasizes the necessity of multidisciplinary approach, including drug therapy, surgical intervention (if necessary), as well as lifestyle modification. The main groups of drugs used in the treatment of CHD, such as antiaggregants, statins, beta-blockers, ACE inhibitors and calcium channel blockers are described. Special attention is given to the role of rehabilitation measures and secondary prevention to prevent complications. The authors emphasise the importance of an individualized approach to each patient depending on the stage of the disease, co morbid conditions and general health status.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-26
DOI
https://doi.org/10.5281/zenodo.14223262
Primary Topic
Healthcare Systems and Public Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comprehensive approach to the treatment of patients with coronary artery disease within medicine framework

Zenodo (CERN European Organization for Nuclear Research)
Healthcare Systems and Public Health
article

Comprehensive approach to the treatment of patients with coronary artery disease within medicine framework

article en

Abstract

The article is devoted to an integrated approach to the treatment of patients with coronary heart disease (CHD) in clinical practice. Modern methods of diagnosis and treatment aimed at improving the quality of life and prognosis of patients with this disease are considered. The article emphasizes the necessity of multidisciplinary approach, including drug therapy, surgical intervention (if necessary), as well as lifestyle modification. The main groups of drugs used in the treatment of CHD, such as antiaggregants, statins, beta-blockers, ACE inhibitors and calcium channel blockers are described. Special attention is given to the role of rehabilitation measures and secondary prevention to prevent complications. The authors emphasise the importance of an individualized approach to each patient depending on the stage of the disease, co morbid conditions and general health status.

Zenodo (CERN European Organization for Nuclear Research)
Chuvash State University (RU), Voronezh State Medical Academy named after N.N. Burdenko (RU), Pirogov Russian National Research Medical University (RU), Kabardino-Balkarian State University (RU), Dagestan State Medical University (RU), Dagestan State University (RU)
Good health and well-being
Openalex Percentile: Top 49%
Healthcare Systems and Public Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comprehensive approach to the treatment of patients with coronary artery disease within medicine framework · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS